Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cassava Sciences Inc (SAVA) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cassava Sciences Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1069530.
Total stock buying since 2005: $30,695,750.
Total stock sales since 2005: $65,943,885.
Total stock option exercises since 2005: $29,172,066.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2024 | 0 | $0 | 4,000 | $15,480 | 248,085 | $5,457,870 |
| 2023 | 137,318 | $3,124,249 | 0 | $0 | 111,423 | $1,903,000 |
| 2022 | 141,159 | $3,040,197 | 0 | $0 | 185,912 | $2,961,659 |
| 2021 | 0 | $0 | 0 | $0 | 101,788 | $5,148,035 |
| 2020 | 272,000 | $1,995,704 | 0 | $0 | 0 | $0 |
| 2019 | 627,899 | $1,693,439 | 0 | $0 | 0 | $0 |
| 2018 | 100,000 | $103,048 | 1,768,660 | $648,464 | 0 | $0 |
| 2014 | 0 | $0 | 0 | $0 | 1,141,082 | $5,179,651 |
| 2013 | 50,000 | $186,727 | 0 | $0 | 236,963 | $971,220 |
| 2012 | 0 | $0 | 0 | $0 | 3,533 | $8,090 |
| 2011 | 5,000 | $21,095 | 501,417 | $2,320,615 | 1,449,329 | $7,542,541 |
| 2010 | 38,983 | $183,890 | 637,860 | $3,709,893 | 0 | $0 |
| 2009 | 136,748 | $333,373 | 9,328,972 | $42,480,008 | 0 | $0 |
| 2008 | 331,235 | $1,632,873 | 600,000 | $5,190,749 | 0 | $0 |
| 2007 | 1,176,661 | $9,261,045 | 718,000 | $6,441,246 | 0 | $0 |
| 2006 | 905,839 | $7,457,222 | 571,054 | $5,137,430 | 0 | $0 |
| 2005 | 288,679 | $1,662,888 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2024-11 | 0 | $0 | 4,000 | $15,480 | 0 | $0 |
| 2024-04 | 0 | $0 | 0 | $0 | 248,085 | $5,457,870 |
| 2023-08 | 48,477 | $831,427 | 0 | $0 | 0 | $0 |
| 2023-05 | 0 | $0 | 0 | $0 | 104,281 | $1,773,516 |
| 2023-03 | 88,841 | $2,292,822 | 0 | $0 | 7,142 | $129,484 |
| 2022-10 | 0 | $0 | 0 | $0 | 28,128 | $26,721 |
| 2022-09 | 0 | $0 | 0 | $0 | 2,802 | $66,099 |
| 2022-08 | 141,159 | $3,040,197 | 0 | $0 | 0 | $0 |
| 2022-06 | 0 | $0 | 0 | $0 | 65,368 | $1,528,303 |
| 2022-05 | 0 | $0 | 0 | $0 | 28,014 | $654,967 |
| 2022-04 | 0 | $0 | 0 | $0 | 49,460 | $426,839 |
| 2022-03 | 0 | $0 | 0 | $0 | 12,140 | $258,730 |
| 2021-09 | 0 | $0 | 0 | $0 | 2,801 | $76,663 |
| 2021-07 | 0 | $0 | 0 | $0 | 2,801 | $56,664 |
| 2021-05 | 0 | $0 | 0 | $0 | 56,030 | $3,000,406 |
| 2021-03 | 0 | $0 | 0 | $0 | 40,156 | $2,014,302 |
| 2020-09 | 272,000 | $1,995,704 | 0 | $0 | 0 | $0 |
| 2019-12 | 617,899 | $1,682,839 | 0 | $0 | 0 | $0 |
| 2019-05 | 10,000 | $10,600 | 0 | $0 | 0 | $0 |
| 2018-10 | 0 | $0 | 512,660 | $224,032 | 0 | $0 |
| 2018-09 | 100,000 | $103,048 | 0 | $0 | 0 | $0 |
| 2018-08 | 0 | $0 | 1,256,000 | $424,432 | 0 | $0 |
| 2014-07 | 0 | $0 | 0 | $0 | 864,599 | $3,925,278 |
| 2014-05 | 0 | $0 | 0 | $0 | 42,897 | $192,607 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-11-29 | Kupiec James William (Chief Medical Officer) | Sale | 4,000 | 3.87 | 15,480 |
| 2024-04-26 | Robertson Sanford (Director) | Option Ex | 69,000 | 22.00 | 1,518,000 |
| 2024-04-23 | Barry Richard (Director) | Option Ex | 176,085 | 22.00 | 3,873,870 |
| 2024-04-18 | Kupiec James William (Chief Medical Officer) | Option Ex | 1,500 | 22.00 | 33,000 |
| 2024-04-17 | Schoen Eric (Chief Financial Officer) | Option Ex | 1,500 | 22.00 | 33,000 |
| 2023-08-23 | Robertson Sanford (Director) | Buy | 30,000 | 17.45 | 523,500 |
| 2023-08-22 | Barry Richard (Director) | Buy | 16,571 | 16.65 | 275,907 |
| 2023-08-21 | Barry Richard (Director) | Buy | 1,906 | 16.80 | 32,020 |
| 2023-05-24 | Barbier Remi (President and CEO) | Option Ex | 85,713 | 16.87 | 1,445,978 |
| 2023-05-10 | Robertson Sanford (Director) | Option Ex | 9,284 | 17.64 | 163,769 |
| 2023-05-01 | Gussin Robert Z (Director) | Option Ex | 9,284 | 17.64 | 163,769 |
| 2023-03-07 | Barry Richard (Director) | Buy | 77,276 | 25.76 | 1,990,629 |
| 2023-03-07 | O Donnell Michael J (Director) | Option Ex | 7,142 | 18.13 | 129,484 |
| 2023-03-06 | Barry Richard (Director) | Buy | 11,565 | 26.13 | 302,193 |
| 2022-10-03 | Friedmann Nadav (Chief Medical Officer) | Option Ex | 18,752 | .95 | 17,814 |
| 2022-09-08 | Robertson Sanford (Director) | Option Ex | 2,802 | 23.59 | 66,099 |
| 2022-08-23 | Kupiec James William (Chief Clinical Dev. Officer) | Buy | 2,500 | 24.44 | 61,100 |
| 2022-08-23 | Barry Richard (Director) | Buy | 36,159 | 23.79 | 860,222 |
| 2022-08-12 | Schoen Eric (Chief Financial Officer) | Buy | 2,500 | 19.95 | 49,875 |
| 2022-08-12 | Robertson Sanford (Director) | Buy | 100,000 | 20.69 | 2,069,000 |
| 2022-06-06 | Barbier Remi (President and CEO) | Option Ex | 65,368 | 23.38 | 1,528,303 |
| 2022-05-27 | Friedmann Nadav (Chief Medical Officer) | Option Ex | 28,014 | 23.38 | 654,967 |
| 2022-04-25 | Barbier Remi (President and CEO) | Option Ex | 49,460 | 8.63 | 426,839 |
| 2022-03-29 | Gussin Robert Z (Director) | Option Ex | 7,470 | 21.95 | 163,929 |
| 2022-03-25 | Robertson Sanford (Director) | Option Ex | 4,670 | 20.30 | 94,801 |
| 2021-09-15 | Gussin Robert Z (Director) | Option Ex | 2,801 | 27.37 | 76,663 |
| 2021-07-20 | Barbier Remi (President and CEO) | Option Ex | 2,801 | 20.23 | 56,664 |
| 2021-05-27 | Barbier Remi (President and CEO) | Option Ex | 56,030 | 53.55 | 3,000,406 |
| 2021-03-30 | Robertson Sanford (Director) | Option Ex | 7,472 | 38.19 | 285,318 |
| 2021-03-17 | Friedmann Nadav (Chief Medical Officer) | Option Ex | 28,015 | 53.55 | 1,500,203 |
| 2021-03-16 | O Donnell Michael J (Director) | Option Ex | 4,669 | 49.00 | 228,781 |
| 2020-09-24 | Barbier Remi (President and CEO) | Buy | 10,000 | 9.59 | 95,900 |
| 2020-09-18 | Robertson Sanford (Director) | Buy | 36,281 | 8.92 | 323,626 |
| 2020-09-17 | Schoen Eric (Chief Financial Officer) | Buy | 12,000 | 7.04 | 84,420 |
| 2020-09-17 | Robertson Sanford (Director) | Buy | 213,719 | 6.98 | 1,491,758 |
| 2019-12-31 | Barbier Remi (President and CEO) | Buy | 100,000 | 5.53 | 553,000 |
| 2019-12-26 | Barbier Remi (President and CEO) | Buy | 10,000 | 4.15 | 41,500 |
| 2019-12-20 | Robertson Sanford (Director) | Buy | 423,788 | 2.20 | 932,333 |
| 2019-12-19 | Schoen Eric (Chief Financial Officer) | Buy | 5,300 | 1.88 | 9,964 |
| 2019-12-19 | Robertson Sanford (Director) | Buy | 76,212 | 1.86 | 141,754 |
| 2019-12-18 | Barbier Remi (President and CEO) | Buy | 2,599 | 1.65 | 4,288 |
| 2019-05-14 | Schoen Eric (Chief Financial Officer) | Buy | 10,000 | 1.06 | 10,600 |
| 2018-10-03 | Boyd Steven | Sale | 512,660 | .44 | 224,032 |
| 2018-09-27 | Robertson Sanford (Director) | Buy | 37,817 | 1.05 | 39,707 |
| 2018-09-26 | Robertson Sanford (Director) | Buy | 30,992 | 1.05 | 32,541 |
| 2018-09-25 | Robertson Sanford (Director) | Buy | 21,420 | 1.00 | 21,420 |
| 2018-09-24 | Robertson Sanford (Director) | Buy | 9,771 | .96 | 9,380 |
| 2018-08-20 | Boyd Steven | Sale | 8,000 | .30 | 2,416 |
| 2018-08-17 | Boyd Steven | Sale | 48,000 | .32 | 15,216 |
| 2018-08-16 | Boyd Steven | Sale | 1,200,000 | .34 | 406,800 |
| 2014-07-14 | Roddy Peter S (chief Fianancial Officer) | Option Ex | 171,591 | 4.54 | 779,023 |
| 2014-07-14 | Barbier Remi (CEO, Chairman of the Board) | Option Ex | 428,981 | 4.54 | 1,947,573 |
| 2014-07-11 | Schoenhard Grant (Chief Scientific Officer) | Option Ex | 128,693 | 4.54 | 584,266 |
| 2014-07-01 | Friedmann Nadav (Chief Operating Officer) | Option Ex | 135,334 | 4.54 | 614,416 |
| 2014-05-27 | Gussin Robert Z (Director) | Option Ex | 42,897 | 4.49 | 192,607 |
| 2014-04-09 | Friedmann Nadav (Chief Operating Officer) | Option Ex | 122,054 | 4.54 | 554,125 |
| 2014-03-21 | Robertson Sanford (Director) | Option Ex | 68,635 | 4.59 | 315,034 |
| 2014-03-21 | O Donnell Michael J (Director) | Option Ex | 42,897 | 4.49 | 192,607 |
| 2013-12-12 | Barbier Remi (CEO, Chairman of the Board) | Option Ex | 39,637 | 3.65 | 144,675 |
| 2013-11-06 | Robertson Sanford (Director) | Buy | 31,838 | 3.76 | 119,710 |
| 2013-11-04 | Robertson Sanford (Director) | Buy | 18,162 | 3.69 | 67,017 |
| 2013-05-08 | Gussin Robert Z (Director) | Option Ex | 111,532 | 4.26 | 474,791 |
| 2013-05-07 | O Donnell Michael J (Director) | Option Ex | 42,897 | 4.10 | 175,877 |
| 2013-05-01 | Robertson Sanford (Director) | Option Ex | 42,897 | 4.10 | 175,877 |
| 2012-12-05 | Barbier Remi (CEO, Chairman of the Board) | Option Ex | 3,533 | 2.29 | 8,090 |
| 2011-10-18 | Friedmann Nadav (Chief Operating Officer) | Sale | 25,000 | 4.44 | 111,000 |
| 2011-10-04 | Perry Craig | Sale | 315,000 | 4.63 | 1,457,190 |
| 2011-10-04 | Friedmann Nadav (Chief Operating Officer) | Sale | 7,000 | 4.59 | 32,116 |
| 2011-10-03 | Perry Craig | Sale | 67,000 | 4.83 | 323,409 |
| 2011-10-03 | Friedmann Nadav (Chief Operating Officer) | Sale | 8,000 | 4.89 | 39,120 |
| 2011-09-30 | Friedmann Nadav (Chief Operating Officer) | Sale | 10,000 | 4.91 | 49,060 |
| 2011-09-15 | Friedmann Nadav (Chief Operating Officer) | Sale | 25,000 | 4.88 | 122,125 |
| 2011-08-08 | Perry Craig | Sale | 44,417 | 4.20 | 186,595 |
| 2011-08-08 | Barbier Remi (CEO, Chairman of the Board) | Buy | 5,000 | 4.22 | 21,095 |
| 2011-07-05 | Friedmann Nadav (Chief Operating Officer) | Option Ex | 625,084 | 5.12 | 3,200,430 |
| 2011-06-22 | Friedmann Nadav (Chief Operating Officer) | Option Ex | 200,000 | 5.12 | 1,024,000 |
| 2011-06-13 | Friedmann Nadav (Chief Operating Officer) | Option Ex | 425,084 | 5.12 | 2,176,430 |
| 2011-06-01 | Friedmann Nadav (Chief Operating Officer) | Option Ex | 96,790 | 5.12 | 495,564 |
| 2011-05-13 | O Donnell Michael J (Director) | Option Ex | 32,811 | 6.76 | 221,802 |
| 2011-03-14 | Barbier Remi (CEO & Chairman of the Board) | Option Ex | 1,968 | 6.10 | 12,004 |
| 2011-02-28 | Schoenhard Grant (Director) | Option Ex | 67,592 | 6.10 | 412,311 |
| 2010-10-04 | Barbier Remi (CEO & Chairman of the Board) | Sale | 15,000 | 6.13 | 91,950 |
| 2010-10-01 | Barbier Remi (CEO & Chairman of the Board) | Sale | 35,000 | 6.23 | 218,050 |
| 2010-09-07 | Barbier Remi (CEO & Chairman of the Board) | Sale | 16,264 | 5.60 | 91,078 |
| 2010-09-03 | Barbier Remi (CEO & Chairman of the Board) | Sale | 12,333 | 5.80 | 71,531 |
| 2010-09-02 | Barbier Remi (CEO & Chairman of the Board) | Sale | 11,097 | 5.87 | 65,139 |
| 2010-09-01 | Barbier Remi (CEO & Chairman of the Board) | Sale | 10,306 | 5.75 | 59,259 |
| 2010-08-09 | Barbier Remi (CEO & Chairman of the Board) | Sale | 6,468 | 5.81 | 37,585 |
| 2010-08-06 | Barbier Remi (CEO & Chairman of the Board) | Sale | 9,496 | 5.53 | 52,541 |
| 2010-08-05 | Barbier Remi (CEO & Chairman of the Board) | Sale | 3,505 | 5.60 | 19,624 |
| 2010-08-04 | Barbier Remi (CEO & Chairman of the Board) | Sale | 6,582 | 5.64 | 37,129 |
| 2010-08-03 | Barbier Remi (CEO & Chairman of the Board) | Sale | 6,457 | 5.75 | 37,108 |
| 2010-08-02 | Barbier Remi (CEO & Chairman of the Board) | Sale | 9,352 | 5.74 | 53,708 |
| 2010-07-16 | Schoenhard Grant (Chief Scientific Officer) | Sale | 1,500 | 5.54 | 8,310 |
| 2010-07-07 | Barbier Remi (CEO and Chairman of the Board) | Sale | 7,071 | 5.37 | 37,964 |
| 2010-07-06 | Barbier Remi (CEO and Chairman of the Board) | Sale | 20,172 | 5.34 | 107,657 |
| 2010-07-02 | Barbier Remi (CEO and Chairman of the Board) | Sale | 11,065 | 5.42 | 59,972 |
| 2010-07-01 | Barbier Remi (CEO and Chairman of the Board) | Sale | 11,692 | 5.42 | 63,382 |
| 2010-06-16 | Schoenhard Grant (Chief Scientific Officer) | Sale | 1,500 | 5.45 | 8,175 |
| 2010-06-03 | Barbier Remi (CEO and Chairman of Board) | Sale | 8,238 | 5.53 | 45,564 |
| 2010-06-02 | Barbier Remi (CEO and Chairman of Board) | Sale | 14,089 | 5.54 | 78,053 |
| 2010-06-01 | Barbier Remi (CEO and Chairman of Board) | Sale | 27,673 | 5.52 | 152,644 |
| 2010-05-27 | Schoenhard Grant (Chief Scientific Officer) | Sale | 10,979 | 5.74 | 63,019 |
| 2010-05-19 | Schoenhard Grant (Chief Scientific Officer) | Sale | 2,486 | 5.77 | 14,344 |
| 2010-05-18 | Schoenhard Grant (Chief Scientific Officer) | Sale | 7,926 | 5.78 | 45,812 |
| 2010-05-17 | Schoenhard Grant (Chief Scientific Officer) | Sale | 5,109 | 5.75 | 29,376 |
| 2010-05-06 | Barbier Remi (CEO and Chairman of BOD) | Sale | 6,576 | 5.61 | 36,884 |
| 2010-05-05 | Barbier Remi (CEO and Chairman of BOD) | Sale | 20,100 | 5.76 | 115,776 |
| 2010-05-04 | Friedmann Nadav (Chief Operating Officer) | Sale | 15,000 | 5.95 | 89,205 |
| 2010-05-04 | Barbier Remi (CEO and Chairman of BOD) | Sale | 11,400 | 5.94 | 67,727 |
| 2010-05-03 | Barbier Remi (CEO and Chairman of BOD) | Sale | 11,924 | 6.14 | 73,177 |
| 2010-05-01 | Roddy Peter S (CFO) | Buy | 3,983 | 3.77 | 15,015 |
| 2010-04-16 | Schoenhard Grant (Chief Scientific Officer) | Sale | 26,500 | 6.29 | 166,685 |
| 2010-04-07 | Barbier Remi (CEO and Chairman of Board) | Sale | 5,800 | 6.23 | 36,128 |
| 2010-04-06 | Barbier Remi (CEO & Chairman of the Board) | Sale | 22,200 | 6.29 | 139,660 |
| 2010-04-05 | Barbier Remi (CEO & Chairman of the Board) | Sale | 10,000 | 6.16 | 61,580 |
| 2010-04-01 | Friedmann Nadav (COO) | Sale | 15,000 | 6.17 | 92,595 |
| 2010-04-01 | Barbier Remi (CEO and Chairman of the Board) | Sale | 12,000 | 6.16 | 73,896 |
| 2010-03-16 | Schoenhard Grant (Chief Scientific Officer) | Buy | 35,000 | 4.83 | 168,875 |
| 2010-03-16 | Schoenhard Grant (Chief Scientific Officer) | Sale | 35,000 | 6.13 | 214,410 |
| 2010-03-11 | O Donnell Michael J (Director) | Sale | 25,000 | 6.14 | 153,600 |
| 2010-03-03 | Barbier Remi (CEO and Chair of Board) | Sale | 5,443 | 6.13 | 33,343 |
| 2010-03-02 | Barbier Remi (CEO and Chair of the Board) | Sale | 14,667 | 6.13 | 89,938 |
| 2010-03-01 | Barbier Remi (CEO and Chair of the Board) | Sale | 29,890 | 6.05 | 180,714 |
| 2010-02-02 | Barbier Remi (CEO, President, Chairman of Bd) | Sale | 20,200 | 5.34 | 107,928 |
| 2010-02-01 | Barbier Remi (CEO, President, Chairman of Bd) | Sale | 29,800 | 5.30 | 158,059 |
| 2010-01-06 | Barbier Remi (CEO, Chairman of Board) | Sale | 14,500 | 5.40 | 78,329 |
| 2010-01-05 | Barbier Remi (CEO, Chairman of Board) | Sale | 19,600 | 5.40 | 105,918 |
| 2010-01-04 | Barbier Remi (CEO, Chairman of Board) | Sale | 15,900 | 5.37 | 85,367 |
| 2009-12-07 | Friedmann Nadav (Chief Operating Officer) | Buy | 15,000 | 5.19 | 77,835 |
| 2009-11-16 | Friedmann Nadav (Chief Operating Officer) | Sale | 15,000 | 5.00 | 75,000 |
| 2009-11-05 | Barbier Remi (Chief Executive Officer,) | Sale | 10,000 | 4.80 | 48,000 |
| 2009-11-04 | Barbier Remi (Chief Executive Officer,) | Sale | 15,000 | 4.81 | 72,105 |
| 2009-11-03 | Barbier Remi (Chief Executive Officer,) | Sale | 15,000 | 4.82 | 72,330 |
| 2009-11-02 | Barbier Remi (Chief Executive Officer,) | Sale | 10,000 | 4.93 | 49,260 |
| 2009-10-15 | Robertson Sanford (Director) | Buy | 50,000 | 2.00 | 100,000 |
| 2009-10-07 | Barbier Remi (CEO) | Sale | 10,000 | 5.34 | 53,430 |
| 2009-10-06 | Barbier Remi (CEO) | Sale | 10,000 | 5.35 | 53,470 |
| 2009-10-05 | Barbier Remi (CEO) | Sale | 10,000 | 5.25 | 52,530 |
| 2009-10-02 | Barbier Remi (Chief Executive Officer) | Sale | 10,000 | 5.11 | 51,120 |
| 2009-10-01 | Barbier Remi (Chief Executive Officer) | Sale | 10,000 | 5.09 | 50,910 |
| 2009-09-29 | Eastbourne Capital Management Llc/ca (10% Owner) | Sale | 2,073 | 4.98 | 10,317 |
| 2009-09-28 | Eastbourne Capital Management Llc/ca (10% Owner) | Sale | 1,556,842 | 4.99 | 7,763,971 |
| 2009-09-25 | Eastbourne Capital Management Llc/ca (10% Owner) | Sale | 1,518,000 | 4.97 | 7,552,049 |
| 2009-09-15 | Barbier Remi (CEO and Chairman of the Board) | Sale | 10,000 | 5.20 | 52,020 |
| 2009-09-14 | Barbier Remi (CEO and Chairman of the Board) | Sale | 7,800 | 5.25 | 40,942 |
| 2009-09-11 | Barbier Remi (CEO) | Sale | 7,300 | 5.27 | 38,485 |
| 2009-09-10 | Barbier Remi (CEO) | Sale | 15,900 | 5.21 | 82,791 |
| 2009-08-31 | Roddy Peter S (Chief Financial Officer) | Buy | 40,000 | 3.19 | 127,600 |
| 2009-08-31 | Roddy Peter S (Chief Financial Officer) | Sale | 40,000 | 5.08 | 203,200 |
Insider trading activities including stock purchases, stock sales, and option exercises of SAVA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cassava Sciences Inc (symbol SAVA, CIK number 1069530) see the Securities and Exchange Commission (SEC) website.